Homburger acted as counsel to Swarovski International Holding in connection with the extension of its revolving credit facility, arranged by, amongst others, UBS Switzerland AG and Credit Suisse (Switzerland). Homburger advised Swarovski International Holding and
Tags :sx3
Homburger acted as counsel to GTT Communications on certain financing aspects related to its recent restructuring efforts. Homburger acted as counsel to GTT Communications in connection with a term loan credit agreement with Wilmington Savings
The Gassmann Group is expanding its shareholding. Fredy Bayard has sold half of its capital to Bernese entrepreneur Stefan Niedermaier. The Groupe is thus underlining its long-term goal of remaining an independent media company anchored
Kellerhals Carrard advised Rentouch, a Swiss based tech company specializing in software for visualizing agile planning events across multiple agile teams with SAFe®, in its sale to Scaled Agile. The sale will enable the company
Galenica and Shop Apotheke Europe are combining the business activities of the specialty pharmacy Mediservice and the online pharmacy shop-apotheke.ch in a joint venture. This combination creates the leading online pharmacy in Switzerland. Shop
Intel Capital, an investor in the future of compute, has invested in Unisers, a Swiss semiconductor metrology company that identifies invisible contamination-caused defects in semiconductor materials. The USD14 million seed financing round was led
Geneva-based cybersecurity firm e-Xpert Solutions and the Vaud-based One Step Beyond Group, both specialized in consulting and cloud integration, have merged under a new structure called Swiss Expert Group. Vischer acted as counsel to One
BianchiSchwald partner Hélène Weidmann (pictured) has been elected as a new member of the Board of Directors of ONE swiss bank. Hélène Weidmann has a strong expertise in the fields of
Swiss law firm Homburger acted as legal counsel to Zürcher Kantonalbank, which served as the mandated lead arranger, agent, security agent and original lender, as well as Credit Suisse (Switzerland) and Migros Bank, acting
Oculis Holding, a global biopharmaceutical company, purposefully driven to save sight and improve eye care, listed its shares on Nasdaq after successfully closing the business combination between European Biotech Acquisition Corp. (“EBAC”). At closing, Oculis
